Aguas Andinas Valuation
Is AGUAS-A undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AGUAS-A when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AGUAS-A (CLP268) is trading above our estimate of fair value (CLP236.76)
Significantly Below Fair Value: AGUAS-A is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AGUAS-A?
Other financial metrics that can be useful for relative valuation.
What is AGUAS-A's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CL$1.60t |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.4x |
Enterprise Value/EBITDA | 8.9x |
PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does AGUAS-A's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 12.3x | ||
IAM Inversiones Aguas Metropolitanas | 11.2x | 9.7% | CL$730.0b |
ESVAL-C Esval | 19.1x | n/a | CL$553.5b |
ESSBIO-C Essbio | 8.9x | n/a | CL$262.9b |
PEHUENCHE Empresa Eléctrica Pehuenche | 10x | n/a | CL$1.5t |
AGUAS-A Aguas Andinas | 12.3x | 21.3% | CL$1.6t |
Price-To-Earnings vs Peers: AGUAS-A is expensive based on its Price-To-Earnings Ratio (12.3x) compared to the peer average (12.3x).
Price to Earnings Ratio vs Industry
How does AGUAS-A's PE Ratio compare vs other companies in the Global Water Utilities Industry?
Price-To-Earnings vs Industry: AGUAS-A is good value based on its Price-To-Earnings Ratio (12.3x) compared to the Global Water Utilities industry average (16.6x).
Price to Earnings Ratio vs Fair Ratio
What is AGUAS-A's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 12.3x |
Fair PE Ratio | 14.4x |
Price-To-Earnings vs Fair Ratio: AGUAS-A is good value based on its Price-To-Earnings Ratio (12.3x) compared to the estimated Fair Price-To-Earnings Ratio (14.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | CL$268.00 | CL$343.33 +28.1% | 12.1% | CL$380.00 | CL$280.00 | n/a | 6 |
Apr ’25 | CL$283.50 | CL$343.33 +21.1% | 12.1% | CL$380.00 | CL$280.00 | n/a | 6 |
Mar ’25 | CL$286.00 | CL$335.00 +17.1% | 11.4% | CL$380.00 | CL$280.00 | n/a | 6 |
Feb ’25 | CL$280.09 | CL$335.00 +19.6% | 11.4% | CL$380.00 | CL$280.00 | n/a | 6 |
Jan ’25 | CL$284.60 | CL$335.00 +17.7% | 11.4% | CL$380.00 | CL$280.00 | n/a | 6 |
Dec ’24 | CL$273.79 | CL$335.00 +22.4% | 11.4% | CL$380.00 | CL$280.00 | n/a | 6 |
Nov ’24 | CL$261.00 | CL$326.67 +25.2% | 15.2% | CL$380.00 | CL$245.00 | n/a | 6 |
Oct ’24 | CL$267.97 | CL$324.17 +21.0% | 15.2% | CL$380.00 | CL$245.00 | n/a | 6 |
Sep ’24 | CL$287.01 | CL$313.00 +9.1% | 14.8% | CL$380.00 | CL$245.00 | n/a | 5 |
Aug ’24 | CL$296.00 | CL$291.40 -1.6% | 11.5% | CL$330.00 | CL$245.00 | n/a | 5 |
Jul ’24 | CL$278.00 | CL$291.40 +4.8% | 11.5% | CL$330.00 | CL$245.00 | n/a | 5 |
Jun ’24 | CL$266.45 | CL$291.40 +9.4% | 11.5% | CL$330.00 | CL$245.00 | n/a | 5 |
May ’24 | CL$244.00 | CL$267.60 +9.7% | 4.4% | CL$280.00 | CL$245.00 | n/a | 5 |
Apr ’24 | CL$225.30 | CL$267.60 +18.8% | 4.4% | CL$280.00 | CL$245.00 | CL$283.50 | 5 |
Mar ’24 | CL$201.00 | CL$267.60 +33.1% | 4.4% | CL$280.00 | CL$245.00 | CL$286.00 | 5 |
Feb ’24 | CL$191.00 | CL$267.60 +40.1% | 4.4% | CL$280.00 | CL$245.00 | CL$280.09 | 5 |
Jan ’24 | CL$195.90 | CL$268.40 +37.0% | 4.6% | CL$280.00 | CL$245.00 | CL$284.60 | 5 |
Dec ’23 | CL$206.00 | CL$268.40 +30.3% | 4.6% | CL$280.00 | CL$245.00 | CL$273.79 | 5 |
Nov ’23 | CL$199.00 | CL$253.80 +27.5% | 8.0% | CL$280.00 | CL$230.00 | CL$261.00 | 5 |
Oct ’23 | CL$187.94 | CL$253.80 +35.0% | 8.0% | CL$280.00 | CL$230.00 | CL$267.97 | 5 |
Sep ’23 | CL$193.29 | CL$245.80 +27.2% | 11.6% | CL$280.00 | CL$205.00 | CL$287.01 | 5 |
Aug ’23 | CL$175.87 | CL$245.80 +39.8% | 11.6% | CL$280.00 | CL$205.00 | CL$296.00 | 5 |
Jul ’23 | CL$148.61 | CL$248.80 +67.4% | 9.9% | CL$280.00 | CL$220.00 | CL$278.00 | 5 |
Jun ’23 | CL$169.99 | CL$248.80 +46.4% | 9.9% | CL$280.00 | CL$220.00 | CL$266.45 | 5 |
May ’23 | CL$150.00 | CL$248.80 +65.9% | 9.9% | CL$280.00 | CL$220.00 | CL$244.00 | 5 |
Apr ’23 | CL$167.00 | CL$248.80 +49.0% | 9.9% | CL$280.00 | CL$220.00 | CL$225.30 | 5 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.